Search

Displaying results 721 - 730 of 10000 in total
  1. Drug

    2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE

    go.drugbank.com/drugs/DB07207
    Experimental

    Synonyms: 2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE
  2. Drug

    5-[4-(2-Hydroxyethyl)-1-piperidinyl]-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione

    go.drugbank.com/drugs/DB03622
    Experimental

    Synonyms: 5-[4-(2-Hydroxyethyl)-1-piperidinyl]-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
  3. Drug

    2-Amino-1H-benzimidazol-5-ol

    go.drugbank.com/drugs/DB03729
    Experimental

    Synonyms: 2-Amino-1H-benzimidazol-5-ol, 5-Hydroxy-2-aminobenzimidazole
  4. Drug

    4-amino-5-aminomethyl-2-methylpyrimidine

    go.drugbank.com/drugs/DB03204
    Experimental

    Synonyms: 2-Methyl-4-amino-5-aminomethylpyrimidine, 4-Amino-2-methylpyrimidine-5-methylamineCategories: Heterocyclic Compounds, 1-Ring
  5. Drug

    2-methyl-5-methylidenepyrimidin-4-imine

    go.drugbank.com/drugs/DB01788
    Experimental

    Synonyms: 2-Methyl-5-methylene-4(5H)-pyrimidinimine, 4-Imino-5-Methidyl-2-Methylpyrimidine
  6. Drug

    Adenylyl-(3'-5')-uridine 3'-monophosphate

    go.drugbank.com/drugs/DB01792
    Experimental

    Synonyms: Adenylyl-(3'-5')-3'-uridylic acid, Adenylyl-(3'-5')-uridine 3'-monophosphate
  7. Drug

    Aminophenazone

    go.drugbank.com/drugs/DB01424
    ApprovedWithdrawn

    Aminophenazone is a pyrazolone with analgesic, anti-inflammatory, and antipyretic properties that carries a risk of agranulocytosis. … The FDA suspended the use of aminophenazone due to its association with agranulocytosis, a life-threatening side effect.[A254242,L43942]

    Categories: Non COX-2 selective NSAIDS, Heterocyclic Compounds, 1-RingSynonyms: 1-Phenyl-2,3-dimethyl-4-(dimethylamino)-5-pyrazolone, 1-Phenyl-2,3-dimethyl-4-dimethylaminopyrazol-5-one
  8. Drug

    Imlunestrant

    go.drugbank.com/drugs/DB19043
    ApprovedInvestigational

    The FDA approved imlunestrant on September 25, 2025 [L54051] as a treatment for estrogen receptor (ER)-positive, HER2-negative, estrogen receptor 1 (ESR1)-mutated advanced or metastatic breast cancer with … [L54046] Imlunestrant works by antagonizing ER transcriptional activity and, by forming an unstable drug-receptor complex, promotes ER degradation via the ubiquitin-proteasome pathway.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingSynonyms: (5r)-5-(4-(2-(3-(fluoromethyl)azetidin-1-yl)ethoxy)phenyl)-8-(trifluoromethyl)-5h-(1)benzopyrano(4,3-c)quinolin-2-ol, 5h-(1)benzopyrano(4,3-c)quinolin-2-ol, 5-(4-(2-(3-(fluoromethyl)-1-azetidinyl)ethoxy)phenyl)-8-(trifluoromethyl)-, (5r)-
  9. Drug

    3'-Fluoro-3'-deoxythymidine 5'-monophosphate

    go.drugbank.com/drugs/DB03195
    Experimental

    Synonyms: 3'-Fluoro-3'-deoxythymidine 5'-phosphate, 5'-Thymidylic acid, 3'-deoxy-3'-fluoro-
  10. Drug

    1-Deoxy-D-xylulose 5-phosphate

    go.drugbank.com/drugs/DB02496
    Experimental

    The proteins that 1-Deoxy-D-xylulose 5-phosphate targets include 1-Deoxy-D-xylulose 5-phosphate reductoisomerase and pyridoxine 5'-phosphate synthase. 1-Deoxy-D-xylulose 5-phosphate is an intermediate … 1-Deoxy-D-xylulose 5-phosphate is a solid. This compound belongs to the pentose phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups.

    Synonyms: 1-Deoxy-D-xylulose 5-phosphate